Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
immunotherapy (18) 18
combinational therapy (17) 17
index medicus (14) 14
cancer (11) 11
chemotherapy (7) 7
humans (7) 7
proteins (7) 7
dendritic cells (6) 6
tumor microenvironment (6) 6
immune response (5) 5
immune system (5) 5
melanoma (5) 5
oncology (5) 5
animals (4) 4
antigens (4) 4
apoptosis (4) 4
cancer therapies (4) 4
health aspects (4) 4
hepatocellular carcinoma (4) 4
immunology (4) 4
pharmacology & pharmacy (4) 4
t cells (4) 4
tumors (4) 4
activation (3) 3
analysis (3) 3
antineoplastic agents - therapeutic use (3) 3
biomarkers (3) 3
cell biology (3) 3
combinational immunotherapy (3) 3
combined modality therapy (3) 3
development and progression (3) 3
drugs (3) 3
genetic therapy (3) 3
life sciences (3) 3
lymphocytes (3) 3
metastasis (3) 3
nanoparticles (3) 3
phase-iii trial (3) 3
resistance (3) 3
review (3) 3
stroma (3) 3
therapy (3) 3
antibodies (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - pharmacology (2) 2
antitumor activity (2) 2
article (2) 2
biochemistry, general (2) 2
breast-cancer (2) 2
cancer therapy (2) 2
care and treatment (2) 2
chemistry, multidisciplinary (2) 2
chemokines (2) 2
clinical trials as topic (2) 2
combinational treatment (2) 2
combinatorial analysis (2) 2
cytotoxicity (2) 2
drug delivery systems (2) 2
drug therapy (2) 2
drug therapy, combination (2) 2
drug-delivery (2) 2
engineering, biomedical (2) 2
fibroblasts (2) 2
hepatoma (2) 2
immunoglobulins (2) 2
immunomodulation (2) 2
immunotherapy - methods (2) 2
in-vitro (2) 2
indoleamine 2,3‐dioxygenase inhibitors (2) 2
ineffective photothermal therapy (2) 2
interleukins (2) 2
killer cells (2) 2
liver cancer (2) 2
lymphocytes t (2) 2
materials science, biomaterials (2) 2
mechanisms (2) 2
medical colleges (2) 2
medical research (2) 2
medicine (2) 2
methods (2) 2
molecular modelling (2) 2
molecular targeted therapy (2) 2
nanoscience & nanotechnology (2) 2
natural-killer-cells (2) 2
neoplasms - drug therapy (2) 2
neoplasms - immunology (2) 2
neoplasms. tumors. oncology. including cancer and carcinogens (2) 2
oncolytic virotherapy (2) 2
original (2) 2
pd-1 (2) 2
pd-1 protein (2) 2
photothermal therapy (2) 2
prevention (2) 2
radiation (2) 2
radiotherapy (2) 2
receptors (2) 2
research (2) 2
solid tumors (2) 2
survival (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma
by Rai, Vikrant and Rai, Vikrant and Abdo, Joe and Abdo, Joe and Alsuwaidan, Abdullah N and Alsuwaidan, Abdullah N and Agrawal, Swati and Agrawal, Swati and Sharma, Poonam and Sharma, Poonam and Agrawal, Devendra K and Agrawal, Devendra K
Molecular and Cellular Biochemistry, ISSN 0300-8177, 1/2018, Volume 437, Issue 1, pp. 13 - 36
Liver cancer is the sixth most common cancer worldwide and 3rd most common cause of cancer-related death. Hepatocellular carcinoma (HCC) represents more than... 
Life Sciences | Biochemistry, general | Molecular targets | Immunostimulation | Immunotherapy | Combinational therapy | Virotherapy | Cellular targets | Medical Biochemistry | Oncology | Hepatocellular carcinoma | Cardiology | NATURAL-KILLER-CELLS | DENDRITIC CELLS | HEPATITIS-C-VIRUS | HEPARANASE INHIBITOR PI-88 | CYTOTOXIC T-LYMPHOCYTES | CELL BIOLOGY | APOPTOSIS-INDUCING LIGAND | VESICULAR STOMATITIS-VIRUS | ONCOLYTIC ADENOVIRUS | TUMOR-ASSOCIATED ANTIGEN | RADIOFREQUENCY ABLATION | Antigens | Immune response | Liver diseases | Dendritic cells | Radiation | Development and progression | Hepatoma | T cells | Radiotherapy | Proteins | Killer cells | Chemotherapy | Drug therapy | Health aspects | Cancer | Pathogenesis | Liver | Effector cells | Cytotoxicity | Activation | Lymphocytes T | Cancer therapies | Liver cancer | Receptors | Lymphocytes | Hepatology | Natural killer cells | Public health | Immune system | Proteoglycans | Cytokines | Immunomodulation | MiRNA | T cell receptors | Ribonucleic acid--RNA | Lymphocytes B | Cellular biology | Antigen-presenting cells | Biomarkers | Solid tumors | Chemokines | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Photosensitizer Micelles Together with IDO Inhibitor Enhance Cancer Photothermal Therapy and Immunotherapy
by Peng, Jinrong and Xiao, Yao and Li, Wenting and Yang, Qian and Tan, Liwei and Jia, Yanpeng and Qu, Ying and Qian, Zhiyong
Advanced Science, ISSN 2198-3844, 05/2018, Volume 5, Issue 5, pp. 1700891 - n/a
The therapeutic outcome of photothermal therapy (PTT) remains impeded by the transparent depth of light. Combining PTT with immunotherapy provides strategies... 
combinational therapy | indoleamine 2,3‐dioxygenase (IDO) inhibitors | nanoparticles | ineffective photothermal therapy | immunotherapy | indoleamine 2,3-dioxygenase (IDO) inhibitors | DRUG-DELIVERY | MATERIALS SCIENCE, MULTIDISCIPLINARY | INDOLEAMINE 2,3-DIOXYGENASE | GOLD NANORODS | NANOSCIENCE & NANOTECHNOLOGY | INFRARED THERMAL THERAPY | COMBINATION | CHEMISTRY, MULTIDISCIPLINARY | CHECKPOINT BLOCKADE | BREAST-CANCER | DOCETAXEL DELIVERY | TUMOR MICROENVIRONMENT | Antigens | Immunoglobulins | Cloning | Breast cancer | Radiation therapy | Bioavailability | Metabolism | Cancer therapies | Variance analysis | Nanoparticles | Studies | Proteins | Chemotherapy | Lasers | Immunotherapy | Immune system | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Immune checkpoint modulators in cancer immunotherapy: Recent advances and combination rationales
by Fan, Li and Li, Yue and Chen, Jia-Yu and Zheng, Yong-Fa and Xu, Xi-Ming
Cancer Letters, ISSN 0304-3835, 08/2019, Volume 456, pp. 23 - 28
As a new hallmark of cancer, immune surveillance evading plays a critical role in carcinogenesis. Through modulating the immune checkpoints, immune cells in... 
Ani-PD-1/L1 | Immune checkpoint modulators | Combinational immunotherapy | Anti-CTLA-4 | Therapy | PD-1 protein | Crosstalk | Clinical trials | Antibodies | Editing | Homeostasis | Carcinogenesis | Modulators | Anticancer properties | Proteins | Carcinogens | Lymphocytes | Immunotherapy | New combinations | Fibroblasts | Conflicts of interest | Tumor necrosis factor-TNF | Immune system | Medical research | Antigens | Immunoglobulins | Immunomodulation | Melanoma | Immunosurveillance | Immune checkpoint | Response rates | Biomarkers | Antitumor activity | Ligands | Autoimmune diseases | Cancer | Apoptosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Immunotherapy for hepatocellular carcinoma: recent advances and future perspectives
by Xu, WQ and Liu, K and Chen, MJ and Sun, JY and McCaughan, GW and Lu, XJ and Ji, JS
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, ISSN 1758-8340, 07/2019, Volume 11, p. 1758835919862692
The introduction of immunotherapies has been a major development in the treatment of many advanced cancers, including hepatocellular carcinoma (HCC). We are... 
GLYPICAN-3 | DENDRITIC CELLS | CLINICAL-TRIAL | PD-1 BLOCKADE | combinational immunotherapy | immune checkpoints | IN-VITRO | ONCOLOGY | immune cell-based therapy | immunotherapy | CHIMERIC-ANTIGEN-RECEPTOR | CTLA-4 | TUMOR MUTATIONAL BURDEN | PHASE-I | hepatocellular carcinoma | T-CELLS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Combined Photothermal Therapy and Immunotherapy: Photosensitizer Micelles Together with IDO Inhibitor Enhance Cancer Photothermal Therapy and Immunotherapy (Adv. Sci. 5/2018)
by Peng, Jinrong and Xiao, Yao and Li, Wenting and Yang, Qian and Tan, Liwei and Jia, Yanpeng and Qu, Ying and Qian, Zhiyong
Advanced Science, ISSN 2198-3844, 05/2018, Volume 5, Issue 5, pp. 1870031 - n/a
Reinvigorating the tumor infiltrating lymphocytes (TILs) is critical for tumor immunotherapy, and photothermal therapy (PTT) and regulation of tumor cell... 
combinational therapy | indoleamine 2,3‐dioxygenase (IDO) inhibitors | nanoparticles | ineffective photothermal therapy | immunotherapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer
by Matos, Ana I and Carreira, Barbara and Peres, Carina and Moura, Liane I.F and Conniot, João and Fourniols, Thibaut and Scomparin, Anna and Martínez-Barriocanal, Águeda and Arango, Diego and Conde, João P and Préat, Véronique and Satchi-Fainaro, Ronit and Florindo, Helena F
Journal of Controlled Release, ISSN 0168-3659, 08/2019, Volume 307, pp. 108 - 138
Colorectal cancer (CRC) is among the five most commonly diagnosed cancers worldwide, constituting 6% of all cancers and the third leading cause of cancer... 
Tumor immune microenvironment | Combinational schemes | Immunotherapy | Nanotechnology | Colorectal cancer | TARGETING DENDRITIC CELLS | RANDOMIZED CONTROLLED-TRIAL | KRAS WILD-TYPE | CHEMISTRY, MULTIDISCIPLINARY | RESECTABLE LIVER METASTASES | METASTATIC COLON-CANCER | PHASE-III TRIAL | CLINICAL-PRACTICE GUIDELINES | FUNCTIONALIZED POLYMERIC NANOPARTICLES | CETUXIMAB PLUS IRINOTECAN | PHARMACOLOGY & PHARMACY | SOLID-LIPID NANOPARTICLES | Prevention | Chemotherapy | Relapse | Biological products | Analysis | Drug therapy | Diseases | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy
by Mkrtichyan, Mikayel and Chong, Namju and Eid, Rasha Abu and Wallecha, Anu and Singh, Reshma and Rothman, John and Khleif, Samir N
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 2013, Volume 1, Issue 1, p. 15
One of the significant tumor immune escape mechanisms and substantial barrier for successful immunotherapy is tumor-mediated inhibition of immune response... 
Combinational immunotherapy | Listeria-based vaccine | PD-1 | Immunotherapy | Cancer vaccines | Cell interaction | Cell receptors | Immune response | Dendritic cells | Analysis | Immunity | Biotechnology industry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Chemokine-based immunotherapy: Delivery systems and combination therapies
by Mohit, Elham and Rafati, Sima
Immunotherapy, ISSN 1750-743X, 08/2012, Volume 4, Issue 8, pp. 807 - 840
A major role of chemokines is to mediate leukocyte migration through interaction with G-protein-coupled receptors. Various delivery systems have been developed... 
combinational therapy | chemokine delivery system | chemokine | cancer | immunotherapy | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | NATURAL-KILLER-CELLS | GAMMA-INDUCIBLE PROTEIN-10 | DEPENDENT ANTITUMOR RESPONSES | POLY D,L-2,4-DIAMINOBUTYRIC ACID | LYMPHOTACTIN TRANSGENE EXPRESSION | IMMUNOLOGY | DNA VACCINE POTENCY | HERPES-SIMPLEX-VIRUS | MONOCYTE CHEMOTACTIC PROTEIN-3 | LYMPHOID-TISSUE CHEMOKINE | Recombinant Fusion Proteins - immunology | Immunotherapy - methods | Antigens, Neoplasm - immunology | Humans | Combined Modality Therapy | Receptors, Chemokine - immunology | Chemokines - genetics | Neoplasms - therapy | Animals | Recombinant Fusion Proteins - genetics | Genetic Vectors | Chemokines - immunology | Genetic Therapy - methods | Proteins | Angiogenesis | Chemokines | Cancer | Immune system | G protein-coupled receptors | Immune response | Dendritic cells | Leukocyte migration | Tumor cells | Immunotherapy | Antibodies | Adjuvants | Antitumor activity | Chemokine receptors
Journal Article
Details down arrow
9. Full Text Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8+ T Cells
by Li, Jing and Li, Yanjian and Lee, Younghee and Jiang, Yu and Lu, Huiping and Zang, Wenjuan and Zhao, Xiaohong and Liu, Liguo and Chen, Yang and Tan, Haidong and Yang, Zhiying and Zhang, Michael Q and Mak, Tak W and Ni, Ling and Dong, Chen
Immunity, ISSN 1074-7613, 04/2018, Volume 48, Issue 4, pp. 773 - 786.e5
The molecular mechanisms whereby CD8 T cells become “exhausted” in the tumor microenvironment remain unclear. Programmed death ligand-1 (PD-L1) is upregulated... 
T cell exhaustion | Eomes | tumor immunity | B7S1 | PD-1 | combinational blockade of immune checkpoints | SURVIVAL | PATHWAYS | FAMILY-MEMBER | IMMUNOLOGY | RECEPTORS | CANCER | EXHAUSTION | B7-H4 | PD-1 protein | CD8 antigen | Cytotoxicity | Hepatocellular carcinoma | Infections | Lymphocytes T | B7 antigen | Liver cancer | Cell activation | Lymphocytes | Immunotherapy | Antigens | Myeloid cells | Statistical analysis | Immune response | Tumor cells | Melanoma | Gene expression | Mucin | Molecular modelling | Exhaustion | PD-L1 protein | Epigenetics | Combinatorial analysis | Tumors | Apoptosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Combinational strategy for high-performance cancer chemotherapy
by Qin, Si-Yong and Cheng, Yin-Jia and Lei, Qi and Zhang, Ai-Qing and Zhang, Xian-Zheng
Biomaterials, ISSN 0142-9612, 07/2018, Volume 171, pp. 178 - 197
The clinical outcomes of conventional mono-chemotherapy of cancers are usually far from satisfactory due to some issues such as tumor heterogeneity and... 
Multidrug resistance (MDR) | Combinational mechanism | Cancer therapy | Therapeutic effect | SYNERGISTIC ANTITUMOR-ACTIVITY | MATERIALS SCIENCE, BIOMATERIALS | ENGINEERING, BIOMEDICAL | CHEMO-PHOTOTHERMAL THERAPY | MESOPOROUS SILICA NANOPARTICLES | MULTIDRUG-RESISTANT CANCER | INDEPENDENT PROSTATE-CANCER | METASTATIC COLORECTAL-CANCER | NEGATIVE BREAST-CANCER | CELL LUNG-CANCER | PHASE-III TRIAL | MOLECULE ANTICANCER DRUGS | Genetic Therapy | Neoplasms - immunology | Humans | Immunotherapy | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Neoplasms - drug therapy | Phototherapy | Antimitotic agents | Drug resistance in microorganisms | Chemotherapy | Development and progression | Drug therapy, Combination | Antineoplastic agents | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights